EDP Sciences logo
Search
Menu
All issues Volume 45 / No 5 (September-October 2005) Reprod. Nutr. Dev., 45 5 (2005) 549-558 References
Free Access
Issue
Reprod. Nutr. Dev.
Volume 45, Number 5, September-October 2005
Page(s) 549 - 558
DOI https://doi.org/10.1051/rnd:2005045
References of Reprod. Nutr. Dev. 45 549-558
  1. Kris-Etherton PM, Shaffer D, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000, 71: S179-S188.
  2. Bang HO, Dyerberg J, Nielson AB. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet 1971, 1: 1143-1144 [PubMed].
  3. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic West-coast Eskimos. Acta Med Scand 1972, 192: 85-94 [PubMed].
  4. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 1975, 28: 958-966 [PubMed].
  5. Hirai A, Terano T, Saito H, Tamura Y, Yoshida S. Clinical and epidemiological studies of eicosapentaenoic acid in Japan. In: Lands WEM (Ed), Polyunsaturated Fatty Acids and Eicosanoids, Champaign, IL, 1987, p 9-24.
  6. Kagawa Y, Nishizawa M, Suzuki M, Miyatake T, Hamamoto T, Goto K, Motonaga E, Izumikawa H, Hirata H, Ebihara A. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitamin 1982, 28: 441-453.
  7. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980, 33: 2657-2661 [PubMed].
  8. Holub BJ. Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care. CMAJ 2002, 166: 608-615 [PubMed].
  9. Hirai A, Hamazaki T, Terano T, Nishikawa T, Tamura Y, Sajiki J. Eicosapentaenoic acid and platelet function in Japanese (letter). Lancet 1980, 2: 1132-1133 [PubMed].
  10. Grant WB. Dietary links to Alzheimer Disease. Alzheimer Dis Rev 1997, 2: 42-55.
  11. Grant WB. Diet and risk of dementia: does fat matter? The Rotterdam study Neurology 2003, 60: 2020-2021.
  12. Kalmijn S, Feskens EJ, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997, 145: 33-41 [PubMed].
  13. Kalmijn S, van Boxtel MPJ, Ocke M, Verschuren WMM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004, 52: 275-280.
  14. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, Aggarwal N, Schenider J. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer's disease. Arch Neurol 2003, 60: 940-946 [CrossRef] [PubMed].
  15. Hibbeln JR, Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62: 1-9 [PubMed].
  16. Noaghiul S, Hibbeln JR. Cross national relationship of seafood consumption and rates of bipolar disorders. Am J Psychiatry 2003, 160: 2222-2227 [CrossRef] [PubMed].
  17. Tanskanen A, Hibbeln JR, Tuomilehto J, Uutela A, Haukkala A, Lehtonen J, Vartiainen E. Fish consumption and depressive symptoms in the general population in Finland. Psychiatr Serv 2001, 52: 529-531 [CrossRef] [PubMed].
  18. Bromberger JT, Harlow S, Avis N, Kravitz HM, Cordal A. Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: The Study of Women's Health Across the Nation (SWAN). Am J Public Health 2004, 94: 1378-1385 [PubMed].
  19. Krause N, Liang J. Cross-cultural variations in depressive symptoms in later life. Int Psychogeriatr 1992, 4 (Suppl 2): 185-202.
  20. O'Connor CM, Gurbel PA, Serebruany VL. Depression and ischemic heart disease. Am Heart J 2004, 140 (Suppl 4): 63-69.
  21. Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR, Burgess JR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995, 62: 761-768 [PubMed].
  22. Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin Pediatr 1986, 26: 406-411.
  23. Stevens LJ, Zentall SS, Abate L, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol Behav 1996, 59: 915-920 [CrossRef] [PubMed].
  24. Young GS, Maharaj NJ, Conquer JA. Blood phospholipid fatty acid analysis of adults with and without Attention Deficit/Hyperactivity Disorder. Lipids 2004, 39: 117-123 [PubMed].
  25. Hirayama S, Hamazaki T, Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur J Clin Nutr 2004, 58: 467-473 [CrossRef] [PubMed].
  26. Stevens L, Zhang W, Peck L, Kuczek T, Grevstad N, Mahon A, Zentall SS, Arnold LE, Burgess J.R. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviours. Lipids 2003, 38: 1007-1021 [PubMed].
  27. Voigt RG, Llorente AM, Jensen CL, Fraley JK, Berretta MC, Heird WC. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J Pediatr 2001, 139: 189-196 [CrossRef] [PubMed].
  28. Spencer T, Biederman J, Wilens T, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry 1998, 59 (Suppl 7): 59-68.
  29. Laidlaw M, Holub BJ. Effects of supplementation with fish oil-derived n-3 fatty acids and $\gamma$-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 2003, 77: 37-42 [PubMed].
  30. Barr WB. Schizophrenia and attention deficit disorder. Two complex disorders of attention. Ann. NY Acad. Sci 2001, 931: 239-250.
  31. Biederman J, Faraone SV, Spencer T, Wilens T, Norman D, Lapey KA, Mick E, Lehman BK, Doyle A. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993, 150: 1792-1798 [PubMed].
  32. Clarke AR, Barry RJ, McCarthy R, Selikowitz M. EEG analysis of children with attention-deficit/hyperactivity disorder and comorbid reading disabilities. J Learn Disabil 2002, 35: 276-285 [PubMed].
  33. Fischer M, Barkley RA, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood common problems and teen CD. J Abnorm Child Psychol 2002, 31: 463-375.
  34. Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D. A psychopathological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent bipolar depression. Acta Psychiatr Scand 2003, 107: 385-389 [CrossRef] [PubMed].
  35. Tramontina S, Schmitz M, Polanczyk G, Rohde LA. Juvenile bipolar disorder in Brazil: clinical and treatment findings. Biol Psychiatry 2003, 53: 1043-1049 [CrossRef] [PubMed].
  36. Willcutt EG, Pennington BF. Comorbidity of reading disability and attention-deficit/hyperactivity disorder: differences by gender and subtype. J Learn Disabil 2000, 33: 179-191 [PubMed].
  37. Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biol Psychiatry 2003, 53: 56-64 [CrossRef] [PubMed].
  38. Assies J, Lieverse R, Vreken P, Wanders RJ, Dingemans PM, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry 2001, 49: 510-522 [CrossRef] [PubMed].
  39. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000, 35: 1305-1312 [PubMed].
  40. Mellor JE, Laugharne JDE, Peet M. Omega-3 fatty acid supplementation in schizophrenia patients. Hum. Psychopharmacol 1996, 11: 39-46.
  41. Taylor KE, Higgins CJ, Calvin CM, Hall JA, Easton T, McDaid AM, Richardson AJ. Dyslexia in adults is associated with clinical signs of fatty acid deficiency. Prostaglandins Leukot Essent Fat Acids 2000, 63: 75-78.
  42. Bjerve KS, Brubakk AM, Fougner KJ, Johnsen H, Midthjell K, Vik T. Omega-3 fatty acids: essential fatty acids with important biological effects, and serum phospholipid fatty acids as markers of dietary omega 3-fatty acid intake. Am J Clin Nutr 1993, 57: 801S-805S [PubMed].
  43. Hjartaker J, Lund E, Bjerve KS. Serum phospholipid fatty acid composition and habitual intake of marine foods registered by a semi-quantitative food frequency questionnaire. Eur J Clin Nutr 1997, 51: 736-742 [CrossRef] [PubMed].
  44. Emken EA, Adolf RO, Gulley RM. Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994, 1213: 277-288 [PubMed].
  45. Ross BM, McKenzie I, Glen I, Bennett CP. Increased levels of ethane, a non-invasive marker of n-3 fatty acid oxidation, in breath of children with attention deficit hyperactivity disorder. Nutr Neurosci 2003, 6: 277-281 [CrossRef] [PubMed].
  46. Conquer JA, Holub BJ. Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores. Lipids 1997, 32: 341-345 [PubMed].
  47. Conquer JA, Holub BJ. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. Lipids 1998, 39: 286-292.
  48. Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ. Effect of exercise on FA profiles in n-3 supplemented and nonsupplemented premenopausal women. Lipids 2002, 37: 947-951 [PubMed].
  49. Clark WF, Parbtani A, Huff MW, Spanner E, de Salis H, Chin-Yee I, Philbrick D, Holub BJ. Flaxseed: a potential treatment for lupus nephritis. Kidney Int 1995, 48: 475-480 [PubMed].
  50. Tarpila S, Aro A, Salminen I, Tarpila A, Kleemola P, Akkila J, Aldercreutz H. The effect of flax seed supplementation in processed foods on serum fatty acids and enterolactone. Eur J Clin Nutr 2002, 56: 157-165 [CrossRef] [PubMed].
  51. Chan JK, McDonald BE, Gerrard JM, Bruce VM, Weaver BJ, Holub BJ. Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thromobogenesis. Lipids 1993, 28: 811-817 [PubMed].
  52. Sanders TA, Hinds A, Pereira CC. Influence of n-3 fatty acids on blood lipids in normal subjects. J Intern Med 1989, 225 (Suppl): 99-104.
  53. Stark KD, Park EJ, Maines VA, Holub BJ. Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial. Am J Clin Nut. 2000, 72: 389-394.
  54. Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes - The EVA Study. Am J Clin Nutr 2003, 77: 803-808 [PubMed].
  55. Adams PB, Lawson S, Sanigorski A, Sinclair AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996, 31 (suppl): S157-S161.
  56. Yao J, Stanley JA, Reddy RD, Keshavan MS, Pettegrew JW. Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry 2002, 15: 823-830.
  57. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem NJ. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J. Lipid Res 2001, 142: 1257-1265.